ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety Study of SGN-CD33A in AML Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01902329
Recruitment Status : Completed
First Posted : July 18, 2013
Last Update Posted : January 5, 2018
Sponsor:
Information provided by (Responsible Party):
Seattle Genetics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 18, 2016
  Actual Study Completion Date : December 8, 2017